|
|
Volumn 73, Issue 6, 2012, Pages
|
|
Overview of treatment options in multiple sclerosis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMITRIPTYLINE;
ANTIINFLAMMATORY AGENT;
BACLOFEN;
BENZODIAZEPINE DERIVATIVE;
BETA INTERFERON;
BETA1A INTERFERON;
CLADRIBINE;
CLONAZEPAM;
FINGOLIMOD;
FUMARIC ACID;
GLATIRAMER;
IMMUNOSUPPRESSIVE AGENT;
INTERFERON BETA SERINE;
LAQUINIMOD;
METHYLPHENIDATE;
MITOXANTRONE;
NATALIZUMAB;
PLACEBO;
SEROTONIN UPTAKE INHIBITOR;
TERIFLUNOMIDE;
ANXIETY;
CARDIOTOXICITY;
CHEST TIGHTNESS;
CHILL;
DEPRESSION;
DISEASE EXACERBATION;
DRUG EFFICACY;
DRUG FEVER;
DRUG INDUCED HEADACHE;
DRUG MECHANISM;
DRUG RESPONSE;
DRUG SAFETY;
DRUG SUBSTITUTION;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
DYSPNEA;
EARLY INTERVENTION;
FATIGUE;
FLU LIKE SYNDROME;
HUMAN;
HYPERTRANSAMINASEMIA;
INJECTION SITE INFLAMMATION;
INJECTION SITE NECROSIS;
INJECTION SITE REACTION;
LIVER TOXICITY;
MULTIPLE SCLEROSIS;
MYALGIA;
NEUROPATHIC PAIN;
OFF LABEL DRUG USE;
PALLIATIVE THERAPY;
PANIC;
PATIENT MONITORING;
PERSONALIZED MEDICINE;
PRIORITY JOURNAL;
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
PROPHYLAXIS;
SHORT SURVEY;
SIDE EFFECT;
SPASTICITY;
URINARY URGENCY;
VITAMIN SUPPLEMENTATION;
|
|
EID: 84863549344
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: 10.4088/JCP.11006nr2c Document Type: Short Survey |
|
Times cited : (8)
|
|
References (0)
|
